• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems

tetano

Editor, Senior Moderator
Vaccine. 2019 Jun 29. pii: S0264-410X(19)30764-9. doi: 10.1016/j.vaccine.2019.06.005. [Epub ahead of print]
[h=1]Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.[/h] Coronel J[SUP]1[/SUP], Behrendt I[SUP]2[/SUP], B?rgin T[SUP]3[/SUP], Anderlei T[SUP]3[/SUP], Sandig V[SUP]4[/SUP], Reichl U[SUP]5[/SUP], Genzel Y[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Driven by the concept of plug-and-play cell culture-based viral vaccine production using disposable bioreactors, we evaluated an orbital shaken bioreactor (OSB) for human influenza A virus production at high cell concentration. Therefore, the OSB model SB10-X was coupled to two hollow fiber-based perfusion systems, namely, tangential flow filtration (TFF) and alternating tangential flow filtration (ATF). The AGE1.CR.pIX avian suspension cells grew to 50 ? 10[SUP]6[/SUP] cells/mL in chemically defined medium, maintaining high cell viabilities with an average specific growth rate of 0.020 h[SUP]-1[/SUP] (doubling time = 32 h). Maximum virus titers in the range of 3.28-3.73 log[SUB]10[/SUB](HA units/100 ?L) were achieved, corresponding to cell-specific virus yields of 1000-3500 virions/cell and productivities of 0.5-2.2 ? 10[SUP]12[/SUP] virions/L/d. This clearly demonstrates the potential of OSB operation in perfusion mode, as results achieved in a reference OSB batch cultivation were 2.64 log[SUB]10[/SUB](HA units/100 ?L), 1286 virions/cell and 1.4 ? 10[SUP]12[/SUP] virions/L/d, respectively. In summary, the SB10-X bioreactor can be operated with ATF and TFF systems, which is to our knowledge the first report regarding OSB operation in perfusion mode. Moreover, the results showed that the system is a promising cultivation system for influenza A virus vaccine production. The OSB disposable bioreactor has the potential for simplifying the scale-up from shake flasks to the large-scale bioreactor, facilitating rapid responses in the event of epidemics or pandemics.
Copyright ? 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.


[h=4]KEYWORDS:[/h] High cell density; Hollow-fiber; Influenza A virus; Orbital shaken bioreactor; Perfusion; Viral vaccine production

PMID: 31266669 DOI: 10.1016/j.vaccine.2019.06.005
 
Back
Top Bottom